• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

接受血液透析的糖尿病尿毒症患者的代谢变化

Metabolic changes in diabetic uremic patients on hemodialysis.

作者信息

Avram M M, Lipner H I, Sadiqali R, Iancu M, Gan A C

出版信息

Trans Am Soc Artif Intern Organs. 1976;22:412-9.

PMID:951859
Abstract

By studying the metabolic values of a nondiabetic and diabetic uremic population we demonstrated the following: 1. Insulin is higher in diabetic than nondiabetic uremic patients. A slight arteriovenous difference across the dialyzer membrane suggests that insulin is dialyzable in small amounts in man. 2. C-peptides are highest in nondiabetics, lower in maturity onset diabetics, and lowest in juvenile diabetics. 3. Growth hormone is higher in diabetics than nondiabetics, decreased in both groups during hemodialysis, and returns to pre-dialysis levels 2 hrs after the completion of dialysis treatment. 4. Plasma triglycerides are elevated in both popualtions during the fasting state anddrop during hemodialysis, rising slowly towards the end of hemodialysis. 5. The majority of diabetics on hemodialysis have low renin levels and do not respond to volume reduction. In the high renin diabetics and high and low renin nondiabetics the plasma renin levels rise in response to volume reduction during hemodialysis. Renin is not dialyzable in man. 6. Thyroid function tests show that diabetic and nondiabetic patients have measurements in the low normal range. Our results reveal significant information concerning metabolic changes which take place in diabetic and nondiabetic uremic patients on hemodialysis and helps to characterize these populations. This report may have implications in better understanding the nature of the problems encountered in these populations and in their management (Table III).

摘要

通过研究非糖尿病和糖尿病尿毒症患者的代谢值,我们得到了以下结果:1. 糖尿病尿毒症患者的胰岛素水平高于非糖尿病尿毒症患者。透析器膜两侧存在轻微的动静脉差异,这表明胰岛素在人体中可少量被透析。2. C肽在非糖尿病患者中最高,在成年发病型糖尿病患者中较低,而在青少年糖尿病患者中最低。3. 糖尿病患者的生长激素水平高于非糖尿病患者,两组患者在血液透析期间生长激素水平均下降,且在透析治疗结束后2小时恢复到透析前水平。4. 空腹状态下,两组患者的血浆甘油三酯水平均升高,血液透析期间下降,在透析快结束时又缓慢上升。5. 大多数接受血液透析的糖尿病患者肾素水平较低,对血容量减少无反应。在高肾素水平的糖尿病患者以及高肾素和低肾素水平的非糖尿病患者中,血液透析期间血容量减少会导致血浆肾素水平升高。肾素在人体中不可透析。6. 甲状腺功能测试表明,糖尿病和非糖尿病患者的检测结果均处于低正常范围内。我们的研究结果揭示了有关接受血液透析的糖尿病和非糖尿病尿毒症患者代谢变化的重要信息,并有助于对这些人群进行特征描述。本报告可能有助于更好地理解这些人群所遇到问题的本质及其管理方法(表III)。

相似文献

1
Metabolic changes in diabetic uremic patients on hemodialysis.接受血液透析的糖尿病尿毒症患者的代谢变化
Trans Am Soc Artif Intern Organs. 1976;22:412-9.
2
Response of plasma immunoreactive active renin, inactive renin, plasma renin activity, and aldosterone to hemodialysis in patients with diabetic nephropathy.糖尿病肾病患者血浆免疫反应性活性肾素、无活性肾素、血浆肾素活性及醛固酮对血液透析的反应。
Clin Nephrol. 1990 Jun;33(6):288-92.
3
1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.1α(OH)D3 一α-羟基胆钙化醇——一种活性维生素 D 类似物。关于慢性透析的尿毒症患者继发性甲状旁腺功能亢进症预防和治疗的临床研究。
Dan Med Bull. 2008 Nov;55(4):186-210.
4
Lipoprotein alterations in hemodialysis: differences between diabetic and nondiabetic patients.血液透析中的脂蛋白改变:糖尿病患者与非糖尿病患者的差异
Metabolism. 2003 Jan;52(1):116-21. doi: 10.1053/meta.2003.50018.
5
Renin, growth hormone and insulin in hemodialyzed uremic diabetics.血液透析的尿毒症糖尿病患者体内的肾素、生长激素和胰岛素
Artif Organs. 1978 Nov;2(4):382-5. doi: 10.1111/j.1525-1594.1978.tb01627.x.
6
Inhibition of arginine- and hypoglycemia- induced growth hormone release by acetate in dialyzed patients.透析患者中乙酸盐对精氨酸和低血糖诱导的生长激素释放的抑制作用。
Clin Nephrol. 1982 Feb;17(2):70-6.
7
The determination of insulin sensitivity in hemodialysis and continuous ambulatory peritoneal dialysis in nondiabetic patients with end-stage renal disease.非糖尿病终末期肾病患者血液透析和持续性非卧床腹膜透析时胰岛素敏感性的测定
Saudi Med J. 2005 May;26(5):786-91.
8
Serum reverse T3 assay for predicting glucose intolerance in uremic patients on dialysis therapy.血清反三碘甲状腺原氨酸检测对预测接受透析治疗的尿毒症患者糖耐量异常的价值
Clin Nephrol. 1987 Apr;27(4):189-98.
9
Serum insulin and insulin-like growth factor binding protein-1 levels in adult patients undergoing peritoneal dialysis.接受腹膜透析的成年患者的血清胰岛素和胰岛素样生长因子结合蛋白-1水平
Adv Perit Dial. 1996;12:71-6.
10
Transfer of native insulin through the peritoneal membrane during CAPD in non-diabetic and diabetic patients.非糖尿病和糖尿病患者持续性非卧床腹膜透析期间天然胰岛素透过腹膜的情况。
Adv Perit Dial. 1995;11:119-22.

引用本文的文献

1
Haemodialysis-induced hypoglycaemia and glycaemic disarrays.血液透析引起的低血糖和血糖紊乱。
Nat Rev Nephrol. 2015 May;11(5):302-13. doi: 10.1038/nrneph.2015.38. Epub 2015 Apr 7.